Results 81 to 90 of about 11,686 (159)
No impact of cancer and plague-relevant FPR1 polymorphisms on COVID-19
Formyl peptide receptor 1 (FPR1) is a pattern-recognition receptor that detects bacterial as well as endogenous danger-associated molecular patterns to trigger innate immune responses by myeloid cells.
Adriana Petrazzuolo +9 more
doaj +1 more source
Late‐Stage Functionalization of Peptides on the Solid Phase
Peptide modifications are essential to control pharmacodynamic and pharmacokinetic properties of peptide drugs. Consequently, strategies that allow for efficient and rapid incorporation of non‐canonical modifications into peptides in parallel formats are highly sought after.
Marius Werner +2 more
wiley +1 more source
Bariatric surgery is an approved treatment for obesity that consistently improves metabolic syndrome, with well-documented beneficial effects on dyslipidemia, cardiovascular risk, nonalcoholic fatty liver disease and glucose homeostasis.
Maryam Mahjoubin-Tehran +6 more
doaj +1 more source
Neutrophils are the key players in inflammatory reactions and the release of superoxide through the NADPH-oxidase upon neutrophil activation contributes to bacterial clearance and surrounding tissue damage.
Lena Björkman +2 more
doaj +1 more source
FPR1: A critical gatekeeper of the heart and brain
G protein-coupled receptors (GPCRs) are currently the most widely focused drug targets in the clinic, exerting their biological functions by binding to chemicals and activating a series of intracellular signaling pathways. Formyl-peptide receptor 1 (FPR1)
Ziyin Zhangsun +9 more
doaj +1 more source
In proliferative diabetic retinopathy (PDR), activated Müller glial cells (MGCs) exhibit increased motility and a fibroblast-like proliferation phenotype that contribute to the formation of fibrovascular membrane.
Ying Yu +13 more
doaj +1 more source
Recycling of internalized cell surface receptors is critical for membrane transport and receptor-mediated signaling. Formyl peptide receptor 1 (FPR1) plays important roles in host defense and inflammatory tissue injury.
Junlin Wang +6 more
doaj +1 more source
Development of potent isoflavone-based formyl peptide receptor 1 (FPR1) antagonists and their effects in gastric cancer cell models. [PDF]
Francavilla F +11 more
europepmc +1 more source
A fluorescent photoaffinity probe for formyl peptide receptor 1 labelling in living cells. [PDF]
Field DH +3 more
europepmc +1 more source
Therapeutic strategies for ocular diseases are undergoing a transformative shift from symptom management to regenerative and disease-modifying approaches.
Caterina Gagliano +2 more
doaj +1 more source

